Page 2 - Trade Name News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hachijuni Bank : Notice of Convocation of the 141st Annual General Meeting of Shareholders

These documents are partial translations of the Japanese originals for reference purposes only. In the event of any discrepancy between these translations and the.

Kabushiki kaisha hachijuni naganoMasaki matsushitaTakayuki kanaiChishu minemuraHachijuni naganoKabushiki kaisha hachijuniKiyohito yamasawaCompensation committeeFulltime company auditor of the bankCompany auditor of the bankNippon credit bank ltdShinshu universityStock companyMiyazawa law officeTashita law officeTokyo stock exchange

Daiki Aluminium Industry : Notice of Convocation Annual General Meeting 2024（210KB）

Daiki Aluminium Industry : Notice of Convocation Annual General Meeting 2024（210KB）
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Kita kuNihon keizai shimbunShigenori hayashiKabushiki kaisha daiki aruminiumuKabushiki kaisha daikiShareholders of the companyOrdinance of the ministry justiceAluminium industry co ltdLocation of the head officeRoyal hotel osakaAcquisition of companyTerm of officeFinancial statements for the companyTokyo stock exchangeVoting rightsRepresentative director

Partner Therapeutics Leukine® (sargramostim) Receives Approval in Japan to Treat Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

Partner Therapeutics Leukine® (sargramostim) Receives Approval in Japan to Treat Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRobert mulroyNobelpharma coInnovation of niigata university medical dental hospitalDevice agencyJapanese pharmaceuticalsDivision of pioneering advanced therapeuticsTanner pharma groupNiigata universityPartner therapeutics incPrnewswire partner therapeutics incTrade nameMedical device agencyProject professorPioneering advanced therapeuticsMedical innovation

Partner Therapeutics Leukine® (sargramostim) Receives Approval in Japan to Treat Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

/PRNewswire/ Partner Therapeutics, Inc. (PTx) announced that its partner Nobelpharma received approval from the Japanese Pharmaceuticals and Medical Device.

United statesRobert mulroyDevice agencyInnovation of niigata university medical dental hospitalJapanese pharmaceuticalsTanner pharma groupDivision of pioneering advanced therapeuticsNobelpharma coNiigata universityPrnewswire partner therapeutics incTrade nameMedical device agencySponsor investigator koh nakataProject professorPioneering advanced therapeuticsMedical innovation

Partner Therapeutics Leukine® (sargramostim) Receives Approval in Japan to Treat Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

United statesRobert mulroyTanner pharma groupNiigata universityDivision of pioneering advanced therapeuticsPrnewswire partner therapeutics incNobelpharma coJapanese pharmaceuticalsDevice agencyPartner therapeutics incInnovation of niigata university medical dental hospitalTrade nameMedical device agencyProject professorPioneering advanced therapeuticsMedical innovation